A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Technology
Laser weapons have come of age and are making their way to the battlefield
News
Society
Timeline: The biggest breakthroughs of the past 70 years
Features
Space
We now know how radiation destroys electronics devices
News
Society
“The gut microbiome will become part of every person’s medical record”
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles